Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: A case-control analysis

Pharmacogenetics and Genomics

Volumn 15, Issue 8, 2005, Pages 547-555

  Shi, Qiuling ^a   Zhang, Zhengdong ^a   Li, Guojun ^a   Pillow, Patricia C ^a   Hernandez, Ladia M ^a   Spitz, Margaret R ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biomarker; Folate metabolism; Genetic susceptibility; Lung cancer; Molecular epidemiology

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; GENOMIC DNA; METHIONINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; PYRIDOXINE;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DIETARY INTAKE; DNA POLYMORPHISM; ETHNOLOGY; FEMALE; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MTR GENE; MTRR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SMOKING;

NICOTIANA TABACUM;

EID: 22944451793     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000170916.96650.70     Document Type: Article

References (68)

1. American Cancer Society Inc. Cancer Facts & Figures 2005. Atlanta, GA: American Cancer Society; 2005.
2. Shields P. Molecular epidemiology of smoking and lung cancer. Oncogene 2002; 21:6870-6876.
3. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 2003; 12:689-698.
4. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 1999; 15:523-526.
5. Goldbohm RA, Voorrips LE. Epidemiology of nutrition and lung cancer. Nestle Nutr Workshop Ser Clin Perform Programme 2000; 4:23-35.
6. Brennan P, Fortes C, Butler J, Agudo A, Benhamou S, Darby S, et al. A multicenter case-control study of diet and lung cancer among non-smokers. Cancer Causes Control 2000; 11:49-58.
7. Mannisto S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004; 13:40-48.
8. Darby S, Whitley E, Doll R, Key T, Silcocks P. Diet, smoking and lung cancer: a case-control study of 1000 cases and 1500 controls in South-West England. Br J Cancer 2001; 84:728-735.
9. Shen H, Wei Q, Pillow PC, Amos CI, Hong WK, Spitz MR. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2003; 12:980-986.
10. Wei Q, Shen H, Wang LE, Duphorne CM, Pillow PC, Guo Z, et al. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev 2003; 12: 963-969.
11. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000; 92:1764-1772.
12. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001; 475:7-20.
13. Ames BN. Micronutrient deficiencies. A major cause of DNA damage. Ann NY Acad Sci 1999; 889:87-106.
14. Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J 1990; 4:1450-1459.
15. Castro R, Rivera I, Ravasco P, Camilo ME, Jakobs C, Blom HJ, et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C - > T and 1298A - > C mutations are associated with DNA hypomethylation. J Med Genet 2004; 41:454-458.
16. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998; 95:3059-3064.
17. Wilson A, Leclerc D, Rosenblatt DS, Gravel RA. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet 1999; 8:2009-2016.
18. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase, cDNA cloning, gene localization, and expression. J Biol Chem 1997; 272:3628-3634.
19. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996; 5:1867-1874.
20. 12) increases risk for spina bifida. Mol Genet Metab 1999; 67:317-323.
21. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001; 157:451-456.
22. Feix A, Fritsche-Polanz R, Kletzmayr J, Vychytil A, Horl WH, Sunder-Plassmann G, et al. Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. Am J Kidney Dis 2001; 38:956-964.
23. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, et al. Methionine synthase reductase 66A - > G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C - > T variant. J Nutr 2004; 134:2985-2990.
24. Molloy AM. Folate and homocysteine interrelationships including genetics of the relevant enzymes. Curr Opin Lipidol 2004; 15:49-57.
25. Miriuka SG, Langman LJ, Evrovski J, Miner SE, D'Mello N, Delgado DH, et al. Genetic polymorphisms predisposing to hyperhomocysteinemia in cardiac transplant patients. Transpl Int 2005; 18:29-35.
26. Gos M, Sliwerska E, Szpecht-Potocka A. Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects. J Appl Genet 2004; 45:363-368.
27. Gueant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romano A, Anello G, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003; 344:189-192.
28. Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, et al. Methionine synthase (MTR) 2756 (A - > G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003; 121:219-224.
29. Bosco P, Gueant-Rodriguez RM, Anello G, Romano A, Namour B, Spada RS, et al. Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75:1036-1038.
30. Brilakis ES, Berger PB, Ballman KV, Rozen R. Methylenetetrahydrofolate reductase (MTHFR) 677C > T and methionine synthase reductase (MTRR) 66A > G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atherosclerosis 2003; 168:315-322.
31. Brown CA, McKinney KQ, Kaufman JS, Gravel RA, Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 2000; 7:197-200.
32. Klerk M, Lievers KJ, Kluijtmans LA, Blom HJ, den Heijer M, Schouten EG, et al. The 2756A > G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res 2003; 110:87-91.
33. Hyndman ME, Bridge PJ, Warnica JW, Fick G, Parsons HG. Effect of heterozygosity for the methionine synthase 2756 A - > G mutation on the risk for recurrent cardiovascular events. Am J Cardiol 2000; 86: 1144-1146, A1149.
34. Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, et al. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 2005; 96:173-180.
35. Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, et al. Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 2002; 3:353-359.
36. Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Taji H, et al. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 2004; 77:351-357.
37. 12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8:825-829.
38. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C - > T and methionine synthase 2756A - > G polymorphisms: a study of 2168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13:2175-2180.
39. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124:453-469.
40. Block G, Coyle LM, Hartman AM, Scoppa SM. Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol 1994; 139:1190-1196.
41. Department of Agriculture ARS. USDA Nutrient Database for Standard Reference, Release 14. Nutrient Data Laboratory Home Page, http:// www.nal.usda.gov/fnic/foodcomp/2001.
42. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001; 97: 3205-3209.
43. 12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism. N Engl J Med 1984; 310:686-690.
44. 12 metabolism in fibroblasts from a patient with megaloblastic anemia and homocystinuria due to a new defect in methionine biosynthesis. J Clin Invest 1984; 74:2149-2156.
45. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002; 41:13378-13385.
46. Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, et al. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 2003; 11:671-678.
47. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Mine RJ, et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000; 67:623-630.
48. O'Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, et al. MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 2002; 107:151-155.
49. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002; 13:239-248.
50. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004; 159:423-443.
51. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003; 12:1222-1226.
52. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787-794.
53. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56:4862-4864.
54. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001; 98:14853-14858.
55. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57:1098-1102.
56. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994; 54:5801-5803.
57. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, et al. Sexual differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 2005; in press.
58. Leal NA, Olteanu H, Banerjee R, Bobik TA. Human ATP: Cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase. J Biol Chem 2004; 279:47536-47542.
59. Henao OL, Piyathilake CJ, Waterbor JW, Funkhouser E, Johanning GL, Heimburger DC, et al. Women with polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS) are less likely to have cervical intraepithelial neoplasia (CIN) 2 or 3. Int J Cancer 2005; 113:991-997.
60. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004; 104:2155-2162.
61. Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, et al. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 2004; 25:1639-1647.
62. Kiffmeyer WR, Langer E, Davies SM, Envall J, Robison LL, Ross JA. Genetic polymorphisms in the Hmong population: implications for cancer etiology and survival. Cancer 2004; 100:411-417.
63. van der Put NM, van der Molen EF, Kluijtmans LA, Heil SG, Trijbels JM, Eskes TK, et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 1997; 90:511-517.
64. Chen J, Stampfer MJ, Ma J, Selhub J, Malinow MR, Hennekens CH, et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001; 154:667-672.
65. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992; 92:686-693.
66. Byers T, Marshall J, Anthony E, Fiedler R, Zielezny M. The reliability of dietary history from the distant past. Am J Epidemiol 1987; 125:999-1011.
67. Pietinen P, Hartman AM, Haapa E, Rasanen L, Haapakoski J, Palmgren J, et al. Reproducibility and validity of dietary assessment instruments. II. A qualitative food frequency questionnaire. Am J Epidemiol 1988; 128:667-676.
68. Goldbohm RA, van't Veer P, van den Brandt PA, van't Hof MA, Brants HA, Sturmans F, et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 1995; 49:420-429.